Geneos Wealth Management Inc. Acquires 24,947 Shares of Schrodinger, Inc. $SDGR

Key Points

• Geneos Wealth Management Inc. increased its stake in Schrodinger, Inc. by 41.6% during the first quarter, now owning 84,943 shares valued at approximately $1.68 million.
• Schrodinger reported an earnings per share (EPS) of ($0.59) for the last quarter, exceeding analysts' expectations of ($0.83), with revenue rising 15.7% year-over-year.
• Analysts have mixed ratings on Schrodinger's stock, with a consensus target price of $27.83, and noted a decrease in target prices from several major firms.

Geneos Wealth Management Inc. raised its stake in Schrodinger, Inc. (NASDAQ:SDGR - Free Report) by 41.6% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 84,943 shares of the company's stock after acquiring an additional 24,947 shares during the quarter. Geneos Wealth Management Inc. owned about 0.12% of Schrodinger worth $1,677,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of SDGR. Point72 Hong Kong Ltd acquired a new position in shares of Schrodinger during the 4th quarter worth about $27,000. ANTIPODES PARTNERS Ltd bought a new stake in shares of Schrodinger in the first quarter worth about $37,000. PNC Financial Services Group Inc. raised its position in shares of Schrodinger by 29.9% during the first quarter. PNC Financial Services Group Inc. now owns 2,956 shares of the company's stock worth $58,000 after purchasing an additional 680 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Schrodinger by 118.5% during the 1st quarter. GAMMA Investing LLC now owns 6,109 shares of the company's stock valued at $121,000 after purchasing an additional 3,313 shares in the last quarter. Finally, Federated Hermes Inc. increased its stake in Schrodinger by 100.0% during the 1st quarter. Federated Hermes Inc. now owns 10,000 shares of the company's stock worth $197,000 after purchasing an additional 5,000 shares in the last quarter. 79.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on the stock. Wall Street Zen lowered shares of Schrodinger from a "hold" rating to a "sell" rating in a research note on Saturday, August 30th. Morgan Stanley reduced their price target on Schrodinger from $28.00 to $19.00 and set an "equal weight" rating for the company in a research report on Monday, August 18th. KeyCorp lowered their price target on Schrodinger from $32.00 to $30.00 and set an "overweight" rating on the stock in a research report on Monday, July 14th. Citigroup downgraded shares of Schrodinger from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $35.00 to $20.00 in a report on Friday, August 15th. Finally, Barclays started coverage on shares of Schrodinger in a research note on Thursday, August 14th. They issued an "overweight" rating and a $25.00 price target for the company. Four analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, Schrodinger currently has an average rating of "Moderate Buy" and a consensus price target of $27.83.

Schrodinger Trading Up 2.2%

Shares of NASDAQ:SDGR traded up $0.41 during trading on Wednesday, reaching $19.52. 284,256 shares of the stock were exchanged, compared to its average volume of 1,145,952. The firm has a market cap of $1.44 billion, a PE ratio of -7.87 and a beta of 1.79. Schrodinger, Inc. has a 12 month low of $16.60 and a 12 month high of $28.47. The stock has a 50-day moving average price of $20.13 and a 200-day moving average price of $21.57.

Schrodinger (NASDAQ:SDGR - Get Free Report) last posted its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) EPS for the quarter, topping analysts' consensus estimates of ($0.83) by $0.24. The firm had revenue of $54.76 million for the quarter, compared to analyst estimates of $52.03 million. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The company's revenue was up 15.7% on a year-over-year basis. During the same quarter last year, the company earned ($0.66) EPS. On average, sell-side analysts expect that Schrodinger, Inc. will post -2.37 earnings per share for the current fiscal year.

Schrodinger Company Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.